Fate Therapeutics, Inc. (FATE) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$330
Total Return
-96.70%
CAGR
-49.45%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -2.35% |
| Median | -7.47% |
| Best | +129.03% |
| Worst | -77.85% |
| % of Windows Positive | 37.0% |
1-Year (252 Trading Days)
| Average | -43.54% |
| Median | -63.89% |
| Best | +153.13% |
| Worst | -92.53% |
| % of Windows Positive | 20.5% |
3-Year (756 Trading Days)
| Average | -91.26% |
| Median | -95.03% |
| Best | -45.70% |
| Worst | -98.21% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -99.29% |
| Average Drawdown | -83.15% |
| Drawdown Duration | 1208 Trading Days (Unrecovered) |
| Sortino Ratio | -0.35 |
| Calmar Ratio | -0.50 |
| CVaR (5%) | -11.42% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +126.53% (+595.46% ann.) | +$12653.07 | $0.00 | $0.00 | $0.00 |
| 2025 | -40.61% | $4060.62 | $0.00 | $0.00 | $0.00 |
| 2024 | -55.88% | $5588.23 | $0.00 | $0.00 | $0.00 |
| 2023 | -62.93% | $6293.36 | $0.00 | $0.00 | $0.00 |
| 2022 | -82.76% | $8275.51 | $0.00 | $0.00 | $0.00 |
| 2021 | -35.65% | $3565.38 | $0.00 | $0.00 | $0.00 |
| 2020 | +364.64% | +$36463.98 | $0.00 | $0.00 | $0.00 |
| 2019 | +52.53% | +$5253.31 | $0.00 | $0.00 | $0.00 |
| 2018 | +109.98% | +$10998.35 | $0.00 | $0.00 | $0.00 |
| 2017 | +143.43% | +$14342.64 | $0.00 | $0.00 | $0.00 |
| 2016 | -25.52% | $2551.92 | $0.00 | $0.00 | $0.00 |
| 2015 | -33.00% | $3300.21 | $0.00 | $0.00 | $0.00 |
| 2014 | -19.90% | $1990.45 | $0.00 | $0.00 | $0.00 |
| 2013 partial | -5.14% (-19.07% ann.) | $513.59 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | October 1, 2013 – February 19, 2020 | +347.28% | +26.44% | +$34728.10 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -24.11% | -95.71% | $2411.44 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +102.01% | +209.99% | +$10200.84 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +2.13% | +2.02% | +$213.06 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -65.86% | -68.05% | $6586.08 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -80.93% | -59.09% | $8092.51 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -42.78% | -27.92% | $4278.36 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.